Risk of Hypertension in Cancer Patients Treated with Aflibercept: A Systematic Review and Meta-Analysis

被引：0
|
作者：
Wei-Xiang Qi
Zan Shen
Li-Na Tang
Yang Yao
机构：
[1] Shanghai Jiao Tong University Affiliated Sixth People’s Hospital,Department of Oncology
来源：
Clinical Drug Investigation | 2014年 / 34卷
关键词：
Bevacizumab; Sunitinib; Pazopanib; Aflibercept; Axitinib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：231 / 240
页数：9
相关论文
共 50 条
  • [1] Risk of Hypertension in Cancer Patients Treated with Aflibercept: A Systematic Review and Meta-Analysis
    Qi, Wei-Xiang
    Shen, Zan
    Tang, Li-Na
    Yao, Yang
    [J]. CLINICAL DRUG INVESTIGATION, 2014, 34 (04) : 231 - 240
  • [2] Risk of gastrointestinal perforation in cancer patients treated with aflibercept: a systematic review and meta-analysis
    Qi, Wei-Xiang
    Shen, Fu
    Qing, Zhang
    Xiao-Mao, Guo
    [J]. TUMOR BIOLOGY, 2014, 35 (11) : 10715 - 10722
  • [3] Risk of hypertension in cancer patients treated with sorafenib: an updated systematic review and meta-analysis
    T Funakoshi
    A Latif
    M D Galsky
    [J]. Journal of Human Hypertension, 2013, 27 : 601 - 611
  • [4] Risk of hypertension in cancer patients treated with sorafenib: an updated systematic review and meta-analysis
    Funakoshi, T.
    Latif, A.
    Galsky, M. D.
    [J]. JOURNAL OF HUMAN HYPERTENSION, 2013, 27 (10) : 601 - 611
  • [5] Incidence and Risk of Hypertension in Cancer Patients Treated With Atezolizumab and Bevacizumab: A Systematic Review and Meta-Analysis
    Jiang, Linhan
    Tan, Xiaoxia
    Li, Jun
    Li, Yaling
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [6] Risk of hypertension with regorafenib in cancer patients: a systematic review and meta-analysis
    Wang, Zexing
    Xu, Jing
    Nie, Weiwei
    Huang, Guichun
    Tang, Jinhai
    Guan, Xiaoxiang
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (02) : 225 - 231
  • [7] Risk of hypertension with regorafenib in cancer patients: a systematic review and meta-analysis
    Zexing Wang
    Jing Xu
    Weiwei Nie
    Guichun Huang
    Jinhai Tang
    Xiaoxiang Guan
    [J]. European Journal of Clinical Pharmacology, 2014, 70 : 225 - 231
  • [8] Risk of Venous Thromboembolic Events in Patients With Cancer Treated With Aflibercept: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Kanukula, Raju
    Ganta, Shruthi
    Sirumalla, Yashaswee
    Salam, Abdul
    Baddam, Ravali
    Pasupuleti, Bhuvana C.
    [J]. AMERICAN JOURNAL OF THERAPEUTICS, 2019, 26 (04) : E549 - E552
  • [9] Incidence and risk of severe infections associated with aflibercept in cancer patients: a systematic review and meta-analysis
    Zhang, Xi
    Ran, Yuge
    Shao, Yongjie
    Wang, Kunjie
    Zhu, Yuanxue
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 81 (01) : 33 - 40
  • [10] Incidence and risk of hypertension with sorafenib in patients with cancer: a systematic review and meta-analysis
    Wu, Shenhong
    Chen, John J.
    Kudelka, Andrzej
    Lu, Janice
    Zhu, Xiaolei
    [J]. LANCET ONCOLOGY, 2008, 9 (02): : 117 - 123
12345